Yung-Jue Bang, MD, PhD July 15th 2015 Yung-Jue Bang, MD, PhD, discusses pembrolizumab for the treatment of advanced gastric cancer. Pembrolizumab was investigated as part of the KEYNOTE-012 study, which looked at the checkpoint inhibitor across several solid tumors. Read MoreLatest...
and the Chairman of the Korean Cancer Association from 2012 to 2014. Dr. Bang has co-authored more than 350 papers in SCI-indexed international journals including New England Journal of Medicine and Lancet. He is primarily interested in the development of new anticancer therapeutics, both clinical...
M.A. Shah, …,Y. Bang, …,R.H. Xu Nature Medicine• Volume 29, Issue 8•2023 2citations Scopus Article Open access Efficacy and safety of maintenance therapy with pamiparib versus placebo for advanced gastric cancer responding to first-line platinum-based chemotherapy: Phase 2 study res...
yung-juebang网络方英柱;韩国首尔国立大学医院方 网络释义 1. 方英柱 对今年ASCO年会上报告的ToGA研究,韩国首尔大学医学院的方英柱(Yung-Jue Bang)教授肯定了其重要性。该研究首次尝 …meeting.dxy.cn|基于6个网页 2. 韩国首尔国立大学医院方 ...和中国医学科学院肿瘤医院徐兵河教授等分别担任主席,韩国首尔国立大...